Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapy

Background: Platinum-based therapy (PBT) can be limited by gastrointestinal adverse events, particularly PBT-related colitis and diarrhea (PCD). We studied clinical features, treatments, and outcomes of PCD. Methods: This was a retrospective study of cancer patients who received PBT and colonoscopic...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Sbeih, Hamzah, Mallepally, Niharika, Goldstein, Ryan, Chen, Ellie, Tang, Tenglong, Dike, Uzoamaka K., Al-Asadi, Mazen, Westin, Shannon, Halperin, Daniel, Wang, Yinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097936/
https://www.ncbi.nlm.nih.gov/pubmed/32231718
http://dx.doi.org/10.7150/jca.37777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097936/
https://www.ncbi.nlm.nih.gov/pubmed/32231718
http://dx.doi.org/10.7150/jca.37777

Ejemplares similares